Preliminary safety and efficacy results from an open-label, multicenter, phase 1 study of RP2 as a single agent and in combination with nivolumab in a cohort of patients with uveal melanoma.

被引：0
|
作者：
Sacco, Joseph J.
Harrington, Kevin Joseph
Olsson-Brown, Anna
Chan, Tze Y.
Nenclares, Pablo
Leslie, Isla
Bommareddy, Praveen
Xie, Ben
Wolff, Johannes
Middleton, Mark R.
机构：
[1] Clatterbridge Canc Ctr, Liverpool, Merseyside, England
[2] Univ Liverpool, Liverpool, Merseyside, England
[3] Inst Canc Res, London, England
[4] Replimune Inc, Woburn, MA USA
[5] Univ Oxford, Dept Oncol, Oxford, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9527
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Long-term safety and efficacy of single-agent lbrutinib in patients with relapsed or refractory mantle cell lymphoma: Updated results of an international, multicenter, open-label phase 2 study
    Dreyling, M.
    Wang, M. L.
    Rule, S.
    Martin, P.
    Goy, A.
    Auer, R.
    Kahl, B. S.
    Jurczak, W.
    Advani, R. H.
    Romaguera, J. E.
    Williams, M. E.
    Barrientos, J. C.
    Chmielowska, E.
    Radford, J.
    Stilgenbauer, S.
    Jedrzejczak, W. W.
    Johnson, P.
    Spurgeon, S. E.
    Zhang, L.
    Baher, L.
    Cheng, M.
    Beaupre, D. M.
    Blum, K. A.
    Oncology Research and Treatment, 2015, 38 : 18 - 19
  • [32] Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study
    Geva, Ravit
    Lopez, Juanita
    Danson, Sarah
    Joensuu, Heikki
    Peer, Avivit
    Harris, Samuel J.
    Souza, Fabricio
    Pereira, Kaline M. C.
    Perets, Ruth
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (05) : 1092 - 1101
  • [33] Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study
    Ravit Geva
    Juanita Lopez
    Sarah Danson
    Heikki Joensuu
    Avivit Peer
    Samuel J. Harris
    Fabricio Souza
    Kaline M. C. Pereira
    Ruth Perets
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1092 - 1101
  • [34] Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease
    Doody, RS
    Geldmacher, DS
    Gordon, B
    Perdomo, CA
    Pratt, RD
    ARCHIVES OF NEUROLOGY, 2001, 58 (03) : 427 - 433
  • [35] Efficacy and safety of lanadelumab in Japanese patients with hereditary angioedema: A phase 3 multicenter, open-label study
    Hide, Michihiro
    Ohsawa, Isao
    Nurse, Christina
    Yu, Ming
    JOURNAL OF DERMATOLOGY, 2023, 50 (11): : 1381 - 1391
  • [36] The Efficacy and Safety of Selinexor in Combination with Ruxolitinib in Ruxolitinib-Treated Myelofibrosis Patients: the Interim Analysis of a Prospective, Open-Label, Multicenter, Parallel-Cohort, Phase 2 Study
    Duan, Minghui
    Ma, Lan
    Wu, Qiuling
    Liang, Hong
    Wang, Wei
    Wu, Shaoling
    Mu, Lijun
    Lin, Hai
    Zhou, Hebing
    Shi, Hong-Xia
    Wang, Jinghua
    Jing, Hongmei
    BLOOD, 2023, 142
  • [37] Efficacy and safety of tolvaptan in patients with malignant ascites: a phase 2, multicenter, open-label, dose-escalation study
    Kudo, Toshihiro
    Murai, Yoshiyuki
    Kojima, Yoshitsugu
    Uehara, Kenji
    Satoh, Taroh
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (03) : 354 - 362
  • [38] Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 study
    Tahara, Shigeyuki
    Murakami, Mami
    Kaneko, Tomomi
    Shimatsu, Akira
    ENDOCRINE JOURNAL, 2017, 64 (07) : 735 - 747
  • [39] Final Results from a Multicenter, Open-Label, Dose-Escalation Phase 1b/2 Study of Single-Agent Oprozomib in Patients with Hematologic Malignancies
    Ghobrial, Irene M.
    Savona, Michael R.
    Vij, Ravi
    Siegel, David S.
    Badros, Ashraf
    Kaufman, Jonathan L.
    Raje, Noopur
    Jakubowiak, Andrzej
    Obreja, Mihaela
    Berdeja, Jesus G.
    BLOOD, 2016, 128 (22)
  • [40] Safety and efficacy of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study
    Paller, Amy
    Becker, Emily
    de Lucas, Raul
    Paris, Maria
    Zhang, Wendy
    Zhang, Zuoshun
    Barcellona, Claire
    Maes, Peter
    Fiorillo, Loretta
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB120 - AB120
12345